Viewing Study NCT04808895

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:20 PM
Ignite Modification Date: 2026-01-07 @ 6:01 AM
Study NCT ID: NCT04808895
Status: UNKNOWN
Last Update Posted: 2021-03-22
First Post: 2021-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
None Thrombosis Pulmonary View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acetylsalicylic acid View
None Heparin View
None Pulmonary thrombosis View
None COVID-19 View
None Platelets View
None Inflammation View
None Respiratoty failure View